Replies to post #20405 on SiNtx Technologies Inc (SINT)

[boston745]

Me too tech doesnt sell for much over revenue. In this case we got 1x revenue. Sometimes companies can manage a slight premium but not usually much. This is why I dont have a problem with the price of Amedica's implant design IP.